...
IONSLARGE

Ionis Pharmaceuticals, Inc.

HealthcareBiotechnology
$81.15
$0.01(+0.68%)
52W$23.95
$86.74
FinancialsValuationvs ALNY
Updated Mar 2, 12:00 AM
RSI45
RS Rating88/99
Beta0.68
Volatility51%
F-Score3/9
Mkt Cap$13.3B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Ionis Pharmaceuticals, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings contraction of 114% provides fundamental context to the price action. Investors should exercise caution due to high volatility (51% annualized), which requires wider risk management.

Relative Strength
88
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.68
vs S&P 500
DEFENSIVE
52W Position
91%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$81.30
50 SMA > 100 SMA$78.20
100 SMA > 150 SMA$69.72
150 SMA > 200 SMA$61.77

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$83.19-2.46%BELOW
50 SMA$81.30-0.18%BELOW
100 SMA$78.20+3.78%ABOVE
150 SMA$69.72+16.39%ABOVE
200 SMA$61.77+31.37%ABOVE

Price Performance

1D+0.7%
1W-4.1%
1M-0.9%
3M-1.9%
6M+90.4%
YTD+1.9%
1Y+144.5%
3Y+31.2%
52-Week Trading Range91% from low
$81.15
52W Low$23.95
52W High$86.74

Technical Indicators

RSI (14)NEUTRAL
44.7
305070
VCP ScoreWARM
6/10
Base depth: 15.5%

Risk Profile

Beta
0.68
52W Vol
51%
ATR
$2.57
Max DD (1Y)
-26%

Volume Analysis

Today
81
50D Avg
1.72M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'25+5%
$-0.93
Q2'25+251%
$0.68
Q3'25+16%
$-0.80
Q4'25-114%
$-1.41
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+12.77%
5 Years:+5.30%
3 Years:+17.14%
TTM:+33.79%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+19.08%

Stock Price CAGR

10 Years:+8.91%
5 Years:+8.47%
3 Years:+31.24%
1 Year:+144.50%

Return on Equity

10Y Avg:-30.6%
5Y Avg:-56.8%
3Y Avg:-80.1%
Last Year:-77.9%

Key Metrics

Market Cap$13.3B
Gross Margin98.3%
Net Margin-40.4%
Piotroski F-Score3/9

More IONS Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

IONS vs ALNYALNYARWRCRSPBEAM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 88 meansIONS outperformed 88% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.68 means 32% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 3/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with WARM status.

Frequently Asked Questions

Is IONS in an uptrend right now?

IONS has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is IONS overbought or oversold?

IONS's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.

Is IONS outperforming the market?

IONS has a Relative Strength (RS) Rating of 88 out of 99. Yes, IONS is a market leader, outperforming 88% of all stocks over the past 12 months.

Where is IONS in its 52-week range?

IONS is trading at $81.15, which is 94% of its 52-week high ($86.74) and 91% above its 52-week low ($23.95).

How volatile is IONS?

IONS has a Beta of 0.68 and 52-week volatility of 51%. It's less volatile than the S&P 500 - generally more stable.